AKTS
Aktis Oncology, Inc.
19.40$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -431.8% | -32,708.2% | -1,175.6% | -1,224.4% | -1,190.2% | -294.4% | – | -110.6% | 992.7% | -987.0% | |
| – | 4.9% | 648.9% | 104.5% | 173.0% | 178.1% | 52.9% | – | 4.1% | 105.9% | 35.8% | |
| – | 171.0% | 23,025.9% | 454.6% | 501.7% | 376.2% | 66.8% | – | 5.4% | 152.0% | 79.0% | |
| – | 42.7% | 2,309.7% | 61.3% | -12.0% | 53.5% | -29.9% | – | -0.1% | 3,966.4% | -49.7% | |
| – | 18.5% | 9,937.4% | 580.8% | 341.2% | 555.9% | 180.6% | – | 13.9% | 192.5% | 147.5% | |
| – | -18.5% | -26,714.4% | -580.8% | -338.9% | -552.6% | -227.6% | – | -253.8% | -12,804.3% | 1,015.3% | |
| – | 1,009.6% | 91,703.2% | 2,185.7% | 2,626.2% | 2,539.1% | 471.0% | – | 120.2% | 12,325.8% | -18.7% | |
| – | 559.3% | 32,280.6% | 429.3% | 1,062.9% | 796.3% | -51.1% | – | -364.4% | 514.2% | 9.6% | |
| – | -450.3% | -42,645.6% | -1,756.4% | -1,565.6% | -1,746.1% | -475.0% | – | -124.5% | 800.3% | -1,134.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.